IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome

OBJECTIVE: The Guillain–Barré syndrome (GBS) is an acute, immune‐mediated disease of peripheral nerves. Plasmablasts and plasma cells play a central role in GBS by producing neurotoxic antibodies. The standard treatment for GBS is high‐dose intravenous immunoglobulins (IVIg), however the working mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Brem, Maarten D., Jacobs, Bart C., van Rijs, Wouter, Fokkink, Willem Jan R., Tio‐Gillen, Anne P., Walgaard, Christa, van Doorn, Pieter A., IJspeert, Hanna, van der Burg, Mirjam, Huizinga, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331722/
https://www.ncbi.nlm.nih.gov/pubmed/30656191
http://dx.doi.org/10.1002/acn3.687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331722/
https://www.ncbi.nlm.nih.gov/pubmed/30656191
http://dx.doi.org/10.1002/acn3.687

Ejemplares similares